Skip to main content

Table 3 Comparisons between patients with and without abdominal obesity presented for each sex

From: Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type 1 diabetes: a cross sectional study

  Abdominal obesity
Women Men
Yes No p a Yes No p a
N 21 65   8 96  
Age (years) 45 (32, 50) 40 (31, 51) 0.81 52 (37, 58) 44 (32, 52) 0.17
Diabetes duration (years) 23 (13, 28) 18 (9, 29) 0.59 20 (10, 44) 21 (12, 33) 0.90
MSCb (nmol/l) 7.1 (5.1, 8.8) 5.0 (2.9, 7.8) 0.030 3.8 (2.5, 5.4) 4.8 (3.1, 7.2) 0.37
MSCb
 Highc 13 (62) 24 (37) 0.007f 1 (12) 26 (27) 0.29f
 Intermediated 7 (33) 17 (26) 3 (38) 37 (38)
 Lowe 1 (5) 24 (37) 4 (50) 33 (34)
 Smokingg 1 (5) 4 (6) > 0.99h 1 (12) 10 (11) > 0.99h
 Physical inactivityi 4 (19) 5 (8) 0.22h 0 10 (11) > 0.99h
Physical activityi
(times per week)
 > 5 7 (33.3) 25 (41) 0.31f 2 (25) 35 (38) 0.82f
 3–5 7 (33.3) 20 (33) 3 (37.5) 29 (31)
 1–2 3 (14.3) 11 (18) 3 (37.5) 19 (20)
 < 1 4 (19) 5 (8) 0 10 (11)
Depression 2 (10) 6 (9) > 0.99h 2 (25) 10 (10) 0.23h
Alexithymia 6 (29) 11 (17) 0.34h 3 (38) 10 (10) 0.060h
Antidepressants 6 (29) 3 (5) 0.006h 0 4 (4) > 0.99h
  1. Data are n (%) or median (q1, q3). aMann–Whitney U test unless otherwise indicated. bMidnight salivary cortisol, c≥ 6.7 nmol/l, d≥ 3.7 to  < 6.7 nmol/l, e< 3.7 nmol/l. fLinear-by-linear association. Missing values (women/men): gn = 3/2. h Fisher’s exact test. Missing values (women/men): in = 4/3